Announcement on Resignation of Senior Management Members
Filed with SSE · · 2 pages · Chinese
Summary by 6ix AI
Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. has announced the resignation of a senior management member, specifically the deputy general manager, Qin Lei.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. on 6ix
Earlier from Shanghai Fudan Zhangjiang Bio Pharmaceutical
- Report for Q1 2026
- Science and Technology for People's Well-being - Achievement of Enterprises on SSE STAR Market and Its Empowerment of People's Livelihood Conference
- Announcement on Voluntary Disclosure of Completion of Inclusion of the First Subject in Phase 1 Clinical Trial of FZ-P001 Sodium for Injection for Visualization of Malignant Lesions during Ovarian Cancer Surgery
- Announcement on Requesting the General Meeting to Authorize the Board of Directors to Issue Shares to Specific Objects by Summary Procedure
- Announcement on Preliminary Earnings Estimate for 2025
Later from Shanghai Fudan Zhangjiang Bio Pharmaceutical
- Announcement on the Resignation of Core Technical Personnel
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Semi-annual Report for 2026
- Announcement on Shareholding Reduction Plan by Shareholder Holding More Than 5% of the Shares
- Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry
Follow Shanghai Fudan Zhangjiang Bio Pharmaceutical into a list and get an email when it puts out news.
Follow Shanghai Fudan Zhangjiang Bio Pharmaceutical